How to safeguard delivery of high-alert i.v. drugs.
Hadaway
L C
LC
Hadaway & Associates, Milner, Ga., USA.
D000925:Anticoagulants / Q000008:administration & dosage; D001993:Bronchodilator Agents / Q000008:administration & dosage; D004298:Dopamine / Q000008:administration & dosage; D015259:Dopamine Agents / Q000008:administration & dosage; D004509:Education, Nursing, Continuing; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage; D007262:Infusions, Intravenous / Q000451:nursing*; D007328:Insulin / Q000008:administration & dosage; D009741:Nursing Staff, Hospital; D011189:Potassium Chloride / Q000008:administration & dosage*; D018570:Risk Assessment; D013806:Theophylline / Q000008:administration & dosage
D000925:Anticoagulants; D001993:Bronchodilator Agents; D015259:Dopamine Agents; D007004:Hypoglycemic Agents; D007328:Insulin; D011189:Potassium Chloride; D006493:Heparin; D013806:Theophylline; D004298:Dopamine